Attached files
| file | filename |
|---|---|
| EX-3.1 - EX-3.1 - Virobay Inc | d748272dex31.htm |
| EX-10.6 - EX-10.6 - Virobay Inc | d748272dex106.htm |
| EX-10.12 - EX-10.12 - Virobay Inc | d748272dex1012.htm |
| EX-10.4 - EX-10.4 - Virobay Inc | d748272dex104.htm |
| EX-4.1 - EX-4.1 - Virobay Inc | d748272dex41.htm |
| EX-5.1 - EX-5.1 - Virobay Inc | d748272dex51.htm |
| EX-10.5 - EX-10.5 - Virobay Inc | d748272dex105.htm |
| EX-10.15 - EX-10.15 - Virobay Inc | d748272dex1015.htm |
| EX-10.14 - EX-10.14 - Virobay Inc | d748272dex1014.htm |
| EX-1.1 - EX-1.1 - Virobay Inc | d748272dex11.htm |
| EX-10.20 - EX-10.20 - Virobay Inc | d748272dex1020.htm |
| EX-10.13 - EX-10.13 - Virobay Inc | d748272dex1013.htm |
| EX-10.17 - EX-10.17 - Virobay Inc | d748272dex1017.htm |
| EX-10.2 - EX-10.2 - Virobay Inc | d748272dex102.htm |
| EX-23.1 - EX-23.1 - Virobay Inc | d748272dex231.htm |
| S-1/A - AMENDMENT NO.1 TO FORM S-1 - Virobay Inc | d748272ds1a.htm |
Exhibit 10.21
Executive Officer Annual Base Salaries
On September 12, 2014, at a meeting of the Board of Directors (the “Board”) of Virobay, Inc. (the “Company”), the Board approved annualized base salaries for the Company’s executive officers and certain employees as set forth below. The annualized base salaries are effective immediately as of the closing of the Company’s initial public offering.
| Name |
Title |
Annualized Base Salary | ||||
|
Robert F. Booth, Ph. D. |
President and Chief Executive Officer |
$ | 415,000 | |||
| James H. Welch |
Chief Financial and Accounting Officer, Secretary and Compliance Officer |
$ | 300,000 | |||
| David B. Karpf, M.D. |
Chief Medical Officer |
$ | 320,000 | |||
| Anantha R. Sudhakar, Ph.D. |
Vice President, Chemistry, Manufacturing and Controls |
$ | 265,000 | |||